220 related articles for article (PubMed ID: 35968869)
21. The burden of single virus and viral coinfections on severe lower respiratory tract infections among preterm infants: a prospective birth cohort study in Brazil.
Arruda E; Jones MH; Escremim de Paula F; Chong D; Bugarin G; Notario G; Matsuno AK; Pitrez PM; Vo P; Suzuki C; Rosario Filho N; Stein RT
Pediatr Infect Dis J; 2014 Oct; 33(10):997-1003. PubMed ID: 25361184
[TBL] [Abstract][Full Text] [Related]
22. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
van Wijhe M; Johannesen CK; Simonsen L; Jørgensen IM; ; Fischer TK
J Infect Dis; 2022 Aug; 226(Suppl 1):S55-S62. PubMed ID: 35426942
[TBL] [Abstract][Full Text] [Related]
23. Lower respiratory tract illness and RSV prophylaxis in very premature infants.
Lacaze-Masmonteil T; Truffert P; Pinquier D; Daoud P; Goldfarb G; Vicaut E; Fauroux B
Arch Dis Child; 2004 Jun; 89(6):562-7. PubMed ID: 15155404
[TBL] [Abstract][Full Text] [Related]
24. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
Moline HL; Tannis A; Toepfer AP; Williams JV; Boom JA; Englund JA; Halasa NB; Staat MA; Weinberg GA; Selvarangan R; Michaels MG; Sahni LC; Klein EJ; Stewart LS; Schlaudecker EP; Szilagyi PG; Schuster JE; Goldstein L; Musa S; Piedra PA; Zerr DM; Betters KA; Rohlfs C; Albertin C; Banerjee D; McKeever ER; Kalman C; Clopper BR; ; McMorrow ML; Dawood FS
MMWR Morb Mortal Wkly Rep; 2024 Mar; 73(9):209-214. PubMed ID: 38457312
[TBL] [Abstract][Full Text] [Related]
25. Model correction of diagnostic coding-based RSV incidence for children 0-4 years in the US.
Nduaguba SO; Tran PT; Winterstein AG
BMC Infect Dis; 2024 Jun; 24(1):617. PubMed ID: 38907351
[TBL] [Abstract][Full Text] [Related]
26. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.
Stockman LJ; Curns AT; Anderson LJ; Fischer-Langley G
Pediatr Infect Dis J; 2012 Jan; 31(1):5-9. PubMed ID: 21817948
[TBL] [Abstract][Full Text] [Related]
27. Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis.
Ambrose CS; Anderson EJ; Simões EA; Wu X; Elhefni H; Park CL; Sifakis F; Groothuis JR
Pediatr Infect Dis J; 2014 Jun; 33(6):576-82. PubMed ID: 24622396
[TBL] [Abstract][Full Text] [Related]
28. Level of maternal antibodies against respiratory syncytial virus (RSV) nucleoprotein at birth and risk of RSV very severe lower respiratory tract infection.
Receveur M; Ottmann M; Reynes JM; Eleouet JF; Galloux M; Receveur A; Ploin D; Fiorini S; Rivat N; Valette M; Lina B; Casalegno JS
Influenza Other Respir Viruses; 2023 Jan; 17(1):e13025. PubMed ID: 36251946
[TBL] [Abstract][Full Text] [Related]
29. Respiratory Syncytial Virus Disease: Immunoprophylaxis Policy Review and Public Health Concerns in Preterm and Young Infants.
Staebler S; Blake S
Policy Polit Nurs Pract; 2021 Feb; 22(1):41-50. PubMed ID: 33050785
[TBL] [Abstract][Full Text] [Related]
30. Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants.
Broughton S; Roberts A; Fox G; Pollina E; Zuckerman M; Chaudhry S; Greenough A
Thorax; 2005 Dec; 60(12):1039-44. PubMed ID: 16227330
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children.
Englund JA; Cohen RA; Bianco V; Domachowske JB; Langley JM; Madhi SA; Zaman K; Bueso A; Ceballos A; Cousin L; Gandhi S; Gruselle O; Jose L; Klein NP; Koen A; Puthanakit T; Shi M; Silas P; Tangsathapornpong A; Teeratakulpisarn J; Vesikari T; Haars G; Leach A; Stoszek SK; Dieussaert I
J Pediatric Infect Dis Soc; 2023 May; 12(5):273-281. PubMed ID: 37142551
[TBL] [Abstract][Full Text] [Related]
32. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
Simoes EA; Carbonell-Estrany X
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
[TBL] [Abstract][Full Text] [Related]
33. What U.S. Obstetricians Need to Know About Respiratory Syncytial Virus.
Debessai H; Jones JM; Meaney-Delman D; Rasmussen SA
Obstet Gynecol; 2024 Mar; 143(3):e54-e62. PubMed ID: 38061043
[TBL] [Abstract][Full Text] [Related]
34. Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings.
Langley JM; Bianco V; Domachowske JB; Madhi SA; Stoszek SK; Zaman K; Bueso A; Ceballos A; Cousin L; D'Andrea U; Dieussaert I; Englund JA; Gandhi S; Gruselle O; Haars G; Jose L; Klein NP; Leach A; Maleux K; Nguyen TLA; Puthanakit T; Silas P; Tangsathapornpong A; Teeratakulpisarn J; Vesikari T; Cohen RA
J Infect Dis; 2022 Aug; 226(3):374-385. PubMed ID: 35668702
[TBL] [Abstract][Full Text] [Related]
35. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.
Groothuis JR; Simoes EA; Hemming VG
Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741
[TBL] [Abstract][Full Text] [Related]
36. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study.
Wildenbeest JG; Billard MN; Zuurbier RP; Korsten K; Langedijk AC; van de Ven PM; Snape MD; Drysdale SB; Pollard AJ; Robinson H; Heikkinen T; Cunningham S; O'Neill T; Rizkalla B; Dacosta-Urbieta A; Martinón-Torres F; van Houten MA; Bont LJ;
Lancet Respir Med; 2023 Apr; 11(4):341-353. PubMed ID: 36372082
[TBL] [Abstract][Full Text] [Related]
37. Association of RSV lower respiratory tract infection and subsequent healthcare use and costs: a Medicaid claims analysis in early-preterm, late-preterm, and full-term infants.
Shi N; Palmer L; Chu BC; Katkin JP; Hall CB; Masaquel AS; Mahadevia PJ
J Med Econ; 2011; 14(3):335-40. PubMed ID: 21524154
[TBL] [Abstract][Full Text] [Related]
38. Respiratory syncytial virus hospitalizations in infants of 28 weeks gestational age and less in the palivizumab era.
Resch B; Egger B; Kurath-Koller S; Urlesberger B
Int J Infect Dis; 2017 Apr; 57():50-53. PubMed ID: 28163166
[TBL] [Abstract][Full Text] [Related]
39. Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age.
Movva N; Suh M; Bylsma LC; Fryzek JP; Nelson CB
J Infect Dis; 2022 Aug; 226(Suppl 2):S213-S224. PubMed ID: 35968874
[TBL] [Abstract][Full Text] [Related]
40. Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model.
Kieffer A; Beuvelet M; Sardesai A; Musci R; Milev S; Roiz J; Lee JKH
J Infect Dis; 2022 Aug; 226(Suppl 2):S282-S292. PubMed ID: 35968866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
